Recent discoveries and new approaches are chipping away at the cancers caused by mutant RAS genes. For the first time drugs that target RAS directly are in human clinical trials.
from RAS Dialogue https://ift.tt/2NHeOSF
Recent discoveries and new approaches are chipping away at the cancers caused by mutant RAS genes. For the first time drugs that target RAS directly are in human clinical trials.